Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $38.8 million.

  • Cellebrite DI's Cost of Revenue rose 1943.61% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.8 million, marking a year-over-year increase of 2002.07%. This contributed to the annual value of $132.4 million for FY2024, which is 1947.06% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Cost of Revenue is $38.8 million, which was up 1943.61% from $38.7 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Cost of Revenue ranged from a high of $38.8 million in Q3 2025 and a low of $16.5 million during Q1 2021
  • In the last 5 years, Cellebrite DI's Cost of Revenue had a median value of $26.9 million in 2023 and averaged $28.1 million.
  • In the last 5 years, Cellebrite DI's Cost of Revenue skyrocketed by 4081.0% in 2022 and then skyrocketed by 510.81% in 2023.
  • Over the past 5 years, Cellebrite DI's Cost of Revenue (Quarter) stood at $21.2 million in 2021, then rose by 11.44% to $23.7 million in 2022, then increased by 25.03% to $29.6 million in 2023, then grew by 20.04% to $35.5 million in 2024, then rose by 9.22% to $38.8 million in 2025.
  • Its Cost of Revenue stands at $38.8 million for Q3 2025, versus $38.7 million for Q2 2025 and $38.8 million for Q1 2025.